- Home
- News
- Articles+
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- News
- Articles
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
Pharma, Healthcare & Lifesciences - Extremely Complex Regulatory Landscape - Key Learnings From Expert GCs
13th Annual Legal Era India Conclave 2024 | Day 3: Panel On Pharma, Healthcare & Lifesciences Catch the replay of the engaging panel discussion from Day 3 of the 13th Annual Legal Era India Conclave 2024, where industry leaders discussed the complex regulatory landscape within the Pharma, Healthcare, and Lifesciences sectors. Key Highlights: Navigating the highly regulated pharma...
ToRead the Full Story, Subscribe to
Access the exclusive LEGAL ERAStories,Editorial and Expert Opinion
13th Annual Legal Era India Conclave 2024 | Day 3: Panel On Pharma, Healthcare & Lifesciences
Catch the replay of the engaging panel discussion from Day 3 of the 13th Annual Legal Era India Conclave 2024, where industry leaders discussed the complex regulatory landscape within the Pharma, Healthcare, and Lifesciences sectors.
Key Highlights:
- Navigating the highly regulated pharma and healthcare industries
- Understanding the evolving regulatory challenges and compliance issues
- Insights from leading General Counsels on managing legal complexities in this space
Featured Panelists:
- Kaizad Adi Hazari, Group General Counsel, The Chatterjee Group (TCG)
- Anumeha Soni, Senior Director, Thermo Fisher Scientific
- Sormistha Ghosh, Group General Counsel and Chief Risk Officer, Strides Pharma
Moderator:
- Ashwin Sapra, Partner (Head - Pharma & Healthcare), Cyril Amarchand Mangaldas
This panel highlighted the intricacies of legal and regulatory challenges within the Pharma and Healthcare industries, offering valuable takeaways from expert General Counsels in the field.
Session Partner: Cyril Amarchand Mangaldas
Don't miss the replay for insights into how regulatory frameworks are evolving and what it takes to stay ahead in this dynamic sector.
#13thAnnualLegalEra #LegalEraConclave2024 #PharmaHealthcareLifesciences #RegulatoryChallenges #HealthcareLaw #PharmaLaw #Compliance #GeneralCounsel #LegalInsights #KaizadAdiHazari #TheChatterjeeGroup #AnumehaSoni #ThermoFisherScientific #SormisthaGhosh #StridesPharma #AshwinSapra #CyrilAmarchandMangaldas #LegalProfessionals #PharmaIndustry #HealthcareIndustry #Lifesciences #RegulatoryFramework #LegalCompliance #LegalComplexities #PharmaCompliance #HealthcareRegulations #LegalTrends #IndustryLeaders #Replay #LegalDiscussion